TheEdgeResearch
Home / Stocks / CATV

Opus Holdings, Inc. (CATV)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$572,810
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
9.86
52-Wk Range
0.0001-0.0003
CEO
Michael Feldenkrais
Country
US
Currency
USD

Opus Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Miami, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $572,810. On trailing twelve-month figures it carries a trailing P/E of -16.90, a net margin of -3.7%. Its beta of 9.86 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-16.90
Price / Sales
0.89
Price / Book
0.04
EV / EBITDA
13.24
Gross margin
39.1%
Operating margin
6.4%
Net margin
-3.7%
Return on equity
—
Debt / equity
0.26
Current ratio
0.76
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
14
IPO date
2013-04-03
Headquarters
Miami, FL, US
About Opus Holdings, Inc.

Opus Holdings, Inc. operates as a business incubator. The company acquires, develops, and transitions private companies into public markets. It provides guidance, financial resources, and market expertise to businesses. The company was formerly known as 4Cable TV International, Inc. and changed its name to Opus Holdings, Inc. in March 2025. [2, 21, 22]

Comparable companies

Opus Holdings, Inc. is most often compared with the following Healthcare names:

CNTRFELLXFGXXYIDCNNGMCNPHCOVATFPAIOFPCYNPPJE
More research on CATV
CATV technical analysis CATV TheEdge Score Compare against peers
Open full interactive analysis & DCF →